Protective effects of cariporide on endothelial dysfunction induced by homocysteine

Pharmacology

Volumn 92, Issue 5-6, 2014, Pages 303-309

  Wu, Shujin ^a,c   Gao, Xiang ^a   Yang, Shehua ^a   Liu, Liying ^c   Ge, Bin ^a   Yang, Qingshan ^b  

^a Departments of Pharmacy   (United States)

^b Gan Su Province Hospital   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cariporide; Endothelial dysfunction; Homocysteine; Nuclear factor B; Oxidative stress

Indexed keywords

2,7 DICHLOROFLUORESCEIN DIACETATE; ACETYLCHOLINE; CARIPORIDE; FLUORESCENT DYE; HOMOCYSTEINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CATALASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA; ARTICLE; BIOCHEMICAL PARAMETER; CHEMICAL PARAMETERS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; ENZYME ACTIVITY; INFANT; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; VASCULAR RING; WESTERN BLOTTING; ANIMAL CELL; ANIMAL TISSUE; CALCIUM CELL LEVEL; CONCENTRATION RESPONSE; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY;

ACETYLCHOLINE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; AORTA; BLOTTING, WESTERN; CALCIUM; ENDOTHELIUM, VASCULAR; GUANIDINES; HOMOCYSTEINE; INTERCELLULAR ADHESION MOLECULE-1; MALE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SODIUM-HYDROGEN ANTIPORTER; SULFONES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892951919     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000356318     Document Type: Article

References (22)

1. Heinz J, Kropf S, Luley C, Dierkes J: Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: A metaanalysis. Am J Kidney Dis 2009; 54: 478-489.
2. Mangoni AA, Jackson SH: Homocysteine and cardiovascular disease: Current evidence and future prospects. Am J Med 2002; 112: 556- 565.
3. Finch JM, Joseph J: Homocysteine, cardiovascular inflammation, and myocardial remodeling. Cardiovasc Hematol Disord Drug Targets 2010; 10: 241-245.
4. Ashfield-Watt PA, Moat SJ, Doshi SN, Mc- Dowell IF: Folate, homocysteine, endothelial function and cardiovascular disease. What is the link Biomed Pharmacother 2001; 55: 425- 433.
5. Topal G, Brunet A, Millanvoye E, Boucher JL, Rendu F, Devynck MA, David-Dufilho M: Homocysteine induces oxidative stress by uncoupling of NO synthase activity through reduction of tetrahydrobiopterin. Free Radic Biol Med 2004; 36: 1532-1541.
6. Roth J, Gebeler M, Ludwig S, Wagner L, Kilian K, Sorg C, Harms E, Schulze-Osthof K, Koch H: Homocysteine inhibits tumor necrosis factor-induced activation of endothelium via modulation of nuclear factor-B activity. Biochim Biophys Acta 2001; 1540: 154-165.
7. Sarigianni M, Tsapas A, Mikhailidis DP, Kaloyianni M, Koliakos G, Fliegel L, Paletas K: Na +/H + exchanger-1: A link with atherogenesis Expert Opin Investig Drugs 2010; 19: 1545-1556.
8. Jenkins EC Jr, Debnath S, Gundry S, Gundry S, Uyar U, Fata JE: Intracellular pH regulation by Na +/H + exchanger-1 (NHE1) is required for growth factor-induced mammary branching morphogenesis. Dev Biol 2012; 365: 71-81.
9. Sasahar T, Yayama K, Matsuzaki T, Tsutsui M, Okamoto H: Na + H + exchanger inhibitor induces vasorelaxation through nitric oxide production in endothelial cells via intracellular acidification-associated Ca 2+ mobilization. Pharmacology 2013; 58: 319-325.
10. Hattori R, Otani H, Moriguchi Y, Matsubara H, Yamamura T, Nakao Y, Omiya H, Osako M, Imamura H: NHE and ICAM-1 expression in hypoxic/reoxygenated coronary microvascular endothelial cells. Am J Physiol Heart Circ Physiol 2001; 280: 2796-2803.
11. Wang S-X, Liu L-Y, Hu M, Liu Y-H: Na +/H + exchanger inhibitor prevented endothelial dysfunction induced by high glucose. J Cardiovasc Pharmacol 2005; 45: 586-590.
12. Wang S, Peng Q, Zhang J, Liu L: Na +/H + exchanger is required for hyperglycaemia-induced endothelial dysfunction via calciumdependent calpain. Cardiovasc Res 2008; 80: 255-262.
13. Tu JH, Liu LY, Zhang XH: Protective effect of Na + -H + exchanger inhibitor cariporide on the injury of vascular endothelial function induced by hypercholesterolemia. Hunan Yi Ke Da Xue Xue Bao 2002; 27: 13-16.
14. Alexandru N, Jardin I, Popov D, Simionescu M, Garcia-Estan J, Salido GM, Rosado JA: Effect of homocysteine on calcium mobilization and platelet function in type diabetes mellitus. J Cell Mol Med 2008; 12: 2015-2026.
15. Vacek TP, Vacek JC, Tyagi SC: Mitochondrial mitophagic mechanisms of myocardial matrix metabolism and remodelling. Arch Physiol Biochem 2012; 118: 31-42.
16. Wang SX, Xiong XM, Song T, Liu LY: Protective effects of cariporide on endothelial dysfunction induced by high glucose. Acta Pharmacol Sin 2005; 26: 329-333.
17. Jacobsen DW: Homocysteine and vitamins in cardiovascular disease. Clin Chem 1998; 44: 1833-1843.
18. Karolczak K, Olas B: Mechanism of action of homocysteine and its thiolactone in hemostasis system. Physiol Res 2009; 58: 623-633.
19. Chen C, Conklin BS, Ren Z, Zhong DS: Homocysteine decreases endothelium-dependent vasorelaxation in porcine arteries. J Surg Res 2002; 102: 22-30.
20. Wu S, Yang Q, Liu Q, Song T, Zhou S, Liu Y, Liu L: Cariporide, a specific Na/H exchanger blocker, inhibits neointimal proliferation induced by advanced glycation end products in a balloon injury rat model. Pharmacology 2013; 91: 123-130.
21. Nemeth ZH, Deitch EA, Lu Q, Szabo C, Hasko G: NHE blockade inhibits chemokine production and NF-kappaB activation in immunostimulated endothelial cells. Am J Physiol Cell Physiol 2002; 283: 396-403.
22. Stromer H, de Groot MC, Horn M, Faul C, Leupold A, Morgan JP, Scholz W, Neubauer S: Na +/H + exchange inhibition with HOE642 improves postischemic recovery due to attenuation of Ca 2+ overload and prolonged acidosis on reperfusion. Circulation 2000; 101: 2749-2755.